Parathyroid hormone-related protein inhibits nitrogen-containing bisphosphonate-induced apoptosis of human periodontal ligament fibroblasts by activating MKP1 phosphatase

Bioengineered. 2021 Dec;12(1):1997-2006. doi: 10.1080/21655979.2021.1928930.

Abstract

Massive production of reactive oxygen species (ROS) in human periodontal ligament fibroblasts (HPdLFs) by nitrogen-containing bisphosphonates (BPs) is the main factor causing BP-related osteonecrosis of the jaw. Further, oxidative stress and apoptosis of fibroblasts induced by ROS are closely associated with the activation of MAPK. Parathyroid hormone-related protein (PTHrP) can block the activity of MAPK by regulating the levels of MAPK phosphatase 1 (MKP1). Therefore, it is speculated that PTHrP can inhibit the apoptosis of HPdLFs caused by nitrogen-containing BP via regulating the expression levels of MKP1. Herein, alendronate sodium salt trihydrate (nitrogen-containing BP, FOS) and HPdLFs were co-cultured for 24 h, 48 h, and 72 h, and the levels of ROS and apoptosis were determined, respectively. After 48 h co-culture, FOS significantly increased the levels of ROS and apoptosis, and high phosphorylation levels of p38, ERK1/2 and p66Shc were found in this study. However, the inhibitors of p38 and ERK1/2 significantly reduced the apoptosis of HPdLFs. Interestingly, PTHrP pre-treatment significantly reduced the phosphorylation levels of p38, ERK1/2, and p66Shc. More importantly, MKP1 inhibitor sanguinarine inhibited the dephosphorylation levels of p38, ERK1/2, and p66Shc caused by PTHrP. Altogether, PTHrP can inhibit nitrogen-containing BP-induced apoptosis of HPdLFs by activating MKP1 phosphatase.

Keywords: Parathyroid hormone-related protein; human periodontal ligament fibroblasts; mapk phosphatase-1; nitrogen-containing bisphosphonates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alendronate / pharmacology
  • Apoptosis / drug effects*
  • Cells, Cultured
  • Diphosphonates / pharmacology*
  • Dual Specificity Phosphatase 1* / genetics
  • Dual Specificity Phosphatase 1* / metabolism
  • Fibroblasts* / cytology
  • Fibroblasts* / drug effects
  • Humans
  • Parathyroid Hormone-Related Protein* / genetics
  • Parathyroid Hormone-Related Protein* / metabolism
  • Parathyroid Hormone-Related Protein* / pharmacology
  • Periodontal Ligament / cytology*

Substances

  • Diphosphonates
  • PTHLH protein, human
  • Parathyroid Hormone-Related Protein
  • DUSP1 protein, human
  • Dual Specificity Phosphatase 1
  • Alendronate

Grants and funding

This work was supported by the Clinical Medicine Technology Innovation Plan of Jinan City, Shandong Province, China (1130372591863599104), the National Natural Science Foundation of China (81802709); the Shandong Provincial Natural Science Foundation, China (ZR2018BH024); the Shandong Provincial Postdoctoral Innovative Talents Funded Scheme; the China Postdoctoral Science Foundation (2019M652407); the Program of Shandong University (2017JC010); the Natural Science Foundation of Jinan (201805046); the Cross-Cutting Technology Innovation Projects of Shandong University (2020JCG002);the Clinical Medicine Technology Innovation Plan of Jinan City, Shandong Province, China [1130372591863599104];the National Natural Science Foundation of China [81802709];the Shandong Provincial Natural Science Foundation, China [ZR2018BH024];the Program of Shandong University (2017JC010); the Natural Science Foundation of Jinan [201805046];the Shandong Provincial Postdoctoral Innovative Talents Funded Scheme;